HAM'S PRIMARY CARE GERIATRICS
(7TH ED) ELITE TEST BANK: 2026/2027
STANDARDS
PART I: THE PRIMER
Mastery of the aging physiologic profile and the 2026 clinical guidelines is non-negotiable for
mitigating multicomplexity and extending functional healthspan. Professional intuition here
separates life-saving intervention from fatal prescribing cascades.
● The 5Ms: Mentation, Mobility, Medications, Multicomplexity, and What Matters Most
dictate every clinical algorithm.
● Beers Criteria (2025/2026): Deprescribe Z-drugs for CBT-I; aggressively monitor
tramadol for SIADH.
● PREVENT Equation (2026): Replaces legacy Pooled Cohort Equations; computes 10-
and 30-year total CVD and Heart Failure risk.
● Anti-Amyloid Therapy: Strict MRI monitoring for ARIA-E (edema) and ARIA-H
(hemorrhage) is mandatory for lecanemab.
● Atypical Presentation: Delirium and falls represent the geriatric equivalent of "chest pain
and fever".
PART II: THE ELITE TEST BANK
Q1: An 82-year-old female presents to the clinic. Her daughter reports the patient has
stopped managing her finances and occasionally forgets to take her medications. Which
domain of the geriatric assessment is primarily compromised? A) Basic Activities of Daily
Living (ADLs) B) Instrumental Activities of Daily Living (IADLs) C) The Frailty Phenotype D)
Somatic symptom functioning
● The Answer: B
● Distractor Analysis: Option A involves fundamental self-care tasks (bathing, feeding),
which are preserved here. Options C and D refer to physiological vulnerability and
psychiatric disorders, respectively. Confusing ADLs with IADLs leads to inaccurate
level-of-care recommendations and premature institutionalization.
● The Mentor's Analysis: IADLs require higher executive functioning (finances, medication
management, transportation). Decline in IADLs is the earliest functional herald of mild
cognitive impairment or early dementia, triggering the need for a targeted cognitive
workup and caregiver support systems prior to a catastrophic failure in basic ADLs.
Q2: Under the 2025/2026 updates to the AGS Beers Criteria, which of the following
medication substitutions is the mandatory first-line approach for an 80-year-old patient
with chronic primary insomnia? A) Replacing zolpidem with eszopiclone B) Replacing
temazepam with low-dose lorazepam C) Deprescribing sedatives and initiating Cognitive
Behavioral Therapy for Insomnia (CBT-I) D) Transitioning to diphenhydramine
● The Answer: C
● Distractor Analysis: Options A and B merely swap one "Z-drug" or benzodiazepine for
, another, both of which are Potentially Inappropriate Medications (PIMs) carrying severe
delirium and fall risks. Option D (diphenhydramine) is highly anticholinergic and strictly
avoided in older adults.
● The Mentor's Analysis: The AGS Beers Alternatives list strictly emphasizes
non-pharmacologic interventions. CBT-I is the definitive gold standard. Chemical sleep
aids in the geriatric patient do not mimic physiological sleep architectures; instead, they
exponentially increase morbidity via syncopal falls and cognitive blunting.
Condition Beers Criteria PIM to Avoid 2025/2026 Recommended
Alternative
Insomnia Zolpidem, Eszopiclone, Cognitive Behavioral Therapy
Benzodiazepines for Insomnia (CBT-I)
Pain NSAIDs, Meperidine Acetaminophen, Topical
Diclofenac
Q3: A 78-year-old male with osteoarthritis is prescribed tramadol. According to the latest
geriatric pharmacology updates, what specific clinical parameter must be monitored
upon initiation? A) Serum creatinine B) Serum sodium C) Uric acid D) Thyroid-stimulating
hormone (TSH)
● The Answer: B
● Distractor Analysis: While renal function (A) is always relevant, it is not the specific,
immediate danger triggered by tramadol. Uric acid (C) and TSH (D) are irrelevant to this
drug's acute adverse profile.
● The Mentor's Analysis: The AGS Beers Criteria specifically added tramadol as a PIM to
use with caution due to the high risk of hyponatremia and Syndrome of Inappropriate
Antidiuretic Hormone Secretion (SIADH). Baseline and follow-up sodium monitoring is a
non-negotiable safety parameter to prevent water intoxication and resulting delirium.
Q4: In the context of the Geriatric 5Ms framework utilized in high-performance 2026
clinical settings, which "M" specifically addresses the integration of competing disease
states and fragmented care pathways? A) Mentation B) Mobility C) Multicomplexity D) What
Matters Most
● The Answer: C
● Distractor Analysis: Mentation (A) and Mobility (B) address specific
physiological/cognitive domains. What Matters Most (D) establishes care goals. Only
Multicomplexity captures the compounding variables of overlapping conditions.
● The Mentor's Analysis: Multicomplexity shifts the provider away from single-disease
guidelines—which often contradict one another—and forces a holistic synthesis. It is the
recognition that treating one pathology (e.g., aggressive diuresis for heart failure) may
trigger a cascade in another (e.g., acute kidney injury, delirium, or falls). Single-disease
logic kills geriatric patients.
Q5: An 85-year-old male is brought to the Geriatric Emergency Room. He has no fever
and no leukocytosis but presents with sudden-onset functional decline, generalized
weakness, and a new fall. What is the most highly suspected pathology? A) Atypical
presentation of an acute infection or sepsis B) Acute ischemic stroke C) Major depressive
disorder D) Normal pressure hydrocephalus (NPH)
● The Answer: A
● Distractor Analysis: Stroke (B) presents with focal deficits. Depression (C) is chronic,
not sudden-onset. NPH (D) features a slow-progressing triad (gait, cognition,
incontinence), not acute collapse. Waiting for classic signs like fever in the elderly will cost
, the patient their life.
● The Mentor's Analysis: Immune senescence blunts the classic systemic inflammatory
response. In the geriatric physiological profile, the brain and the musculoskeletal system
act as the "canary in the coal mine." Sepsis manifests as encephalopathy (delirium) and
profound weakness (falls). Treat the functional decline as a life-threatening physiological
crisis.
Q6: Following the 2024/2025 NIA-AA criteria updates, the biological staging of
Alzheimer's disease in clinical practice now heavily relies on which of the following
diagnostic tools? A) Clinical presentation of memory deficits alone B) Mini-Mental State
Examination (MMSE) scoring C) Plasma-based biomarkers, specifically phosphorylated tau 217
D) Brain biopsy
● The Answer: C
● Distractor Analysis: Purely clinical definitions (A, B) have been superseded by biological
definitions. Brain biopsy (D) is unnecessarily invasive and completely outside standard
practice.
● The Mentor's Analysis: The 2024/2026 paradigm shift redefined Alzheimer's as a
biological continuum rather than a purely clinical syndrome. Accurate Core 1 plasma
biomarkers, like phosphorylated tau 217, now allow primary care and geriatric specialists
to confirm amyloid and tau pathology without immediate reliance on costly PET scans or
invasive lumbar punctures, fundamentally altering early diagnostic workflows.
Q7: Which equation is mandated by the 2025/2026 AHA/ACC guidelines to estimate
cardiovascular risk in adults aged 30-79, replacing the legacy Pooled Cohort Equations?
A) Framingham Risk Score B) PREVENT Equations C) ASCVD Risk Estimator Plus D)
CHA2DS2-VASc
● The Answer: B
● Distractor Analysis: Framingham (A) and ASCVD Plus (C) are legacy tools now
considered obsolete for primary prevention screening. CHA2DS2-VASc (D) is specific to
stroke risk in atrial fibrillation.
● The Mentor's Analysis: The PREVENT calculator is revolutionary because it integrates
cardiovascular, kidney, and metabolic data (including optional UACR and HbA1c) to
predict both 10- and 30-year risk for total CVD, including Heart Failure.
Risk Tool Primary Output Key 2026 Integration
Pooled Cohort Equations 10-Year ASCVD Obsolete for new primary care
baselines.
PREVENT Equations 10- & 30-Year Total CVD + HF Incorporates metabolic/renal
health (eGFR, UACR, HbA1c).
Q8: A 72-year-old patient is taking ciprofloxacin for a urinary tract infection. Her
medication list includes warfarin. According to the AGS Beers Criteria, what is the
primary risk of this combination? A) Sudden cardiac death from QTc prolongation B) Tendon
rupture C) Increased bleeding risk due to drug-drug interaction D) Subtherapeutic INR leading
to thrombosis
● The Answer: C
● Distractor Analysis: While fluoroquinolones can cause QTc prolongation (A) and tendon
rupture (B), the specific Beers Criteria warning for the warfarin/ciprofloxacin combination
is the severe elevation of INR and subsequent catastrophic bleeding. Option D is the
exact opposite of the physiological mechanism.
● The Mentor's Analysis: Ciprofloxacin powerfully inhibits CYP450 enzymes responsible
(7TH ED) ELITE TEST BANK: 2026/2027
STANDARDS
PART I: THE PRIMER
Mastery of the aging physiologic profile and the 2026 clinical guidelines is non-negotiable for
mitigating multicomplexity and extending functional healthspan. Professional intuition here
separates life-saving intervention from fatal prescribing cascades.
● The 5Ms: Mentation, Mobility, Medications, Multicomplexity, and What Matters Most
dictate every clinical algorithm.
● Beers Criteria (2025/2026): Deprescribe Z-drugs for CBT-I; aggressively monitor
tramadol for SIADH.
● PREVENT Equation (2026): Replaces legacy Pooled Cohort Equations; computes 10-
and 30-year total CVD and Heart Failure risk.
● Anti-Amyloid Therapy: Strict MRI monitoring for ARIA-E (edema) and ARIA-H
(hemorrhage) is mandatory for lecanemab.
● Atypical Presentation: Delirium and falls represent the geriatric equivalent of "chest pain
and fever".
PART II: THE ELITE TEST BANK
Q1: An 82-year-old female presents to the clinic. Her daughter reports the patient has
stopped managing her finances and occasionally forgets to take her medications. Which
domain of the geriatric assessment is primarily compromised? A) Basic Activities of Daily
Living (ADLs) B) Instrumental Activities of Daily Living (IADLs) C) The Frailty Phenotype D)
Somatic symptom functioning
● The Answer: B
● Distractor Analysis: Option A involves fundamental self-care tasks (bathing, feeding),
which are preserved here. Options C and D refer to physiological vulnerability and
psychiatric disorders, respectively. Confusing ADLs with IADLs leads to inaccurate
level-of-care recommendations and premature institutionalization.
● The Mentor's Analysis: IADLs require higher executive functioning (finances, medication
management, transportation). Decline in IADLs is the earliest functional herald of mild
cognitive impairment or early dementia, triggering the need for a targeted cognitive
workup and caregiver support systems prior to a catastrophic failure in basic ADLs.
Q2: Under the 2025/2026 updates to the AGS Beers Criteria, which of the following
medication substitutions is the mandatory first-line approach for an 80-year-old patient
with chronic primary insomnia? A) Replacing zolpidem with eszopiclone B) Replacing
temazepam with low-dose lorazepam C) Deprescribing sedatives and initiating Cognitive
Behavioral Therapy for Insomnia (CBT-I) D) Transitioning to diphenhydramine
● The Answer: C
● Distractor Analysis: Options A and B merely swap one "Z-drug" or benzodiazepine for
, another, both of which are Potentially Inappropriate Medications (PIMs) carrying severe
delirium and fall risks. Option D (diphenhydramine) is highly anticholinergic and strictly
avoided in older adults.
● The Mentor's Analysis: The AGS Beers Alternatives list strictly emphasizes
non-pharmacologic interventions. CBT-I is the definitive gold standard. Chemical sleep
aids in the geriatric patient do not mimic physiological sleep architectures; instead, they
exponentially increase morbidity via syncopal falls and cognitive blunting.
Condition Beers Criteria PIM to Avoid 2025/2026 Recommended
Alternative
Insomnia Zolpidem, Eszopiclone, Cognitive Behavioral Therapy
Benzodiazepines for Insomnia (CBT-I)
Pain NSAIDs, Meperidine Acetaminophen, Topical
Diclofenac
Q3: A 78-year-old male with osteoarthritis is prescribed tramadol. According to the latest
geriatric pharmacology updates, what specific clinical parameter must be monitored
upon initiation? A) Serum creatinine B) Serum sodium C) Uric acid D) Thyroid-stimulating
hormone (TSH)
● The Answer: B
● Distractor Analysis: While renal function (A) is always relevant, it is not the specific,
immediate danger triggered by tramadol. Uric acid (C) and TSH (D) are irrelevant to this
drug's acute adverse profile.
● The Mentor's Analysis: The AGS Beers Criteria specifically added tramadol as a PIM to
use with caution due to the high risk of hyponatremia and Syndrome of Inappropriate
Antidiuretic Hormone Secretion (SIADH). Baseline and follow-up sodium monitoring is a
non-negotiable safety parameter to prevent water intoxication and resulting delirium.
Q4: In the context of the Geriatric 5Ms framework utilized in high-performance 2026
clinical settings, which "M" specifically addresses the integration of competing disease
states and fragmented care pathways? A) Mentation B) Mobility C) Multicomplexity D) What
Matters Most
● The Answer: C
● Distractor Analysis: Mentation (A) and Mobility (B) address specific
physiological/cognitive domains. What Matters Most (D) establishes care goals. Only
Multicomplexity captures the compounding variables of overlapping conditions.
● The Mentor's Analysis: Multicomplexity shifts the provider away from single-disease
guidelines—which often contradict one another—and forces a holistic synthesis. It is the
recognition that treating one pathology (e.g., aggressive diuresis for heart failure) may
trigger a cascade in another (e.g., acute kidney injury, delirium, or falls). Single-disease
logic kills geriatric patients.
Q5: An 85-year-old male is brought to the Geriatric Emergency Room. He has no fever
and no leukocytosis but presents with sudden-onset functional decline, generalized
weakness, and a new fall. What is the most highly suspected pathology? A) Atypical
presentation of an acute infection or sepsis B) Acute ischemic stroke C) Major depressive
disorder D) Normal pressure hydrocephalus (NPH)
● The Answer: A
● Distractor Analysis: Stroke (B) presents with focal deficits. Depression (C) is chronic,
not sudden-onset. NPH (D) features a slow-progressing triad (gait, cognition,
incontinence), not acute collapse. Waiting for classic signs like fever in the elderly will cost
, the patient their life.
● The Mentor's Analysis: Immune senescence blunts the classic systemic inflammatory
response. In the geriatric physiological profile, the brain and the musculoskeletal system
act as the "canary in the coal mine." Sepsis manifests as encephalopathy (delirium) and
profound weakness (falls). Treat the functional decline as a life-threatening physiological
crisis.
Q6: Following the 2024/2025 NIA-AA criteria updates, the biological staging of
Alzheimer's disease in clinical practice now heavily relies on which of the following
diagnostic tools? A) Clinical presentation of memory deficits alone B) Mini-Mental State
Examination (MMSE) scoring C) Plasma-based biomarkers, specifically phosphorylated tau 217
D) Brain biopsy
● The Answer: C
● Distractor Analysis: Purely clinical definitions (A, B) have been superseded by biological
definitions. Brain biopsy (D) is unnecessarily invasive and completely outside standard
practice.
● The Mentor's Analysis: The 2024/2026 paradigm shift redefined Alzheimer's as a
biological continuum rather than a purely clinical syndrome. Accurate Core 1 plasma
biomarkers, like phosphorylated tau 217, now allow primary care and geriatric specialists
to confirm amyloid and tau pathology without immediate reliance on costly PET scans or
invasive lumbar punctures, fundamentally altering early diagnostic workflows.
Q7: Which equation is mandated by the 2025/2026 AHA/ACC guidelines to estimate
cardiovascular risk in adults aged 30-79, replacing the legacy Pooled Cohort Equations?
A) Framingham Risk Score B) PREVENT Equations C) ASCVD Risk Estimator Plus D)
CHA2DS2-VASc
● The Answer: B
● Distractor Analysis: Framingham (A) and ASCVD Plus (C) are legacy tools now
considered obsolete for primary prevention screening. CHA2DS2-VASc (D) is specific to
stroke risk in atrial fibrillation.
● The Mentor's Analysis: The PREVENT calculator is revolutionary because it integrates
cardiovascular, kidney, and metabolic data (including optional UACR and HbA1c) to
predict both 10- and 30-year risk for total CVD, including Heart Failure.
Risk Tool Primary Output Key 2026 Integration
Pooled Cohort Equations 10-Year ASCVD Obsolete for new primary care
baselines.
PREVENT Equations 10- & 30-Year Total CVD + HF Incorporates metabolic/renal
health (eGFR, UACR, HbA1c).
Q8: A 72-year-old patient is taking ciprofloxacin for a urinary tract infection. Her
medication list includes warfarin. According to the AGS Beers Criteria, what is the
primary risk of this combination? A) Sudden cardiac death from QTc prolongation B) Tendon
rupture C) Increased bleeding risk due to drug-drug interaction D) Subtherapeutic INR leading
to thrombosis
● The Answer: C
● Distractor Analysis: While fluoroquinolones can cause QTc prolongation (A) and tendon
rupture (B), the specific Beers Criteria warning for the warfarin/ciprofloxacin combination
is the severe elevation of INR and subsequent catastrophic bleeding. Option D is the
exact opposite of the physiological mechanism.
● The Mentor's Analysis: Ciprofloxacin powerfully inhibits CYP450 enzymes responsible
